BIODESIX INC — Director's Dealing 2025

Oct 2, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2025-09-30

Reporting Person: PATIENCE JOHN (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-09-30	Common Stock	M	1144	—	Acquired	21518	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-09-30	Restricted Stock Units	$	M	1144	Disposed		Common Stock (1144)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	107664	Indirect
Common Stock	241480	Indirect
Common Stock	2649	Indirect

Footnotes

F1: These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025.

F2: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

F3: The Reporting Person is the sole general partner of Patience Enterprises LP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

F4: The Reporting Person is the sole trustee of John Patience Living Trust (July 23, 1993).

F5: These RSUs vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.